![William Conkling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Conkling
Direttore/Membro del Consiglio presso
IDT CORPORATION
Patrimonio netto: 2 M $ in data 30/06/2026
Profilo
William Conkling is currently Director at Day Three Labs, Inc. and Cornerstone Pharmaceuticals, Inc. Mr. Conkling is also Independent Director at IDT Corp.
starting in 2026 and Chief Commercial Officer at Protara Therapeutics, Inc. starting in 2025.
Formerly, Mr. Conkling was President & Chief Executive Officer at Rafael Holdings, Inc. from 2023 to 2025, Independent Director at Cyclo Therapeutics, Inc. from 2023 to 2025, and Vice President-Sales, Marketing & Market Access at Immunomedics, Inc. from 2018 to 2021.
Education includes undergraduate studies at Fordham University and an MBA from The Leonard N Stern School of Business, conferred in 1998.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/11/2025 | 490.770 ( 0,96% ) | 2 M $ | 30/06/2026 | |
| 02/06/2026 | 69.992 ( 0,12% ) | 267 369 $ | 30/06/2026 | |
| 09/06/2026 | 673 ( 0% ) | 39 142 $ | 30/06/2026 |
Posizioni attive di William Conkling
| Società | Posizione | Inizio |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Corporate Officer/Principal | 02/06/2025 |
| IDT CORPORATION | Direttore/Membro del Consiglio | 09/06/2026 |
Day Three Labs, Inc.
 Day Three Labs, Inc. Information Technology ServicesTechnology Services Provides proprietary technology services | Direttore/Membro del Consiglio | - |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di William Conkling
| Società | Posizione | Fine |
|---|---|---|
| RAFAEL HOLDINGS, INC. | Amministratore Delegato | 31/05/2025 |
| CYCLO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 25/03/2025 |
| IMMUNOMEDICS, INC. | Vendite & Marketing | 01/03/2021 |
Formazione di William Conkling
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
69
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Cyclo Therapeutics, Inc.
 Cyclo Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and sells cyclodextrins and related products | Health Technology |
IDT Corp.
 IDT Corp. Major TelecommunicationsCommunications Provides telecommunication and financial technology services | Communications |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Commercial Services |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rafael Holdings, Inc.
 Rafael Holdings, Inc. Real Estate DevelopmentFinance Operates as holding company with interest in real estate and pharmaceutical sector | Finance |
Protara Therapeutics, Inc.
 Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Day Three Labs, Inc.
Day Three Labs, Inc. Information Technology ServicesTechnology Services Provides proprietary technology services | Technology Services |
